Multi-electrode arrays (MEAs) provide a noninvasive interface with sub-millisecond temporal resolution and long-term, ...
Cogent Biosciences (COGT) shares have surged after pivotal bezuclastinib data in imatinib-resistant aGIST. Read the latest ...
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...
Zacks Investment Research on MSN
Roche's breast cancer drug cuts risk of death by 30% in phase III
Roche RHHBY announced positive new data from a pre-specified interim analysis of its late-stage breast cancer study on ...
The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway ...
Abstract: Zero voltage transition (ZVT) is a soft switching technology renowned for its superior performance. While the judicious selection of topology, parameters, and control modes can notably ...
Eustachian tube dysfunction often determines whether a routine ear infection clears quickly or develops into a persistent ...
Per- and polyfluoroalkyl substances (PFAS) are a group of nearly 10,000 long-lasting chemical compounds that stay in the ...
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistan ...
Background Chronic hepatitis B virus (HBV) infection disproportionately affects people living with HIV, who are often excluded from functional cure studies. Objective This study investigates CD8+ T ...
GNODEVAE is an innovative computational framework that integrates Graph Attention Networks (GAT), Neural Ordinary Differential Equations (NODE), and Variational Autoencoders (VAE). It addresses three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results